New drug aims to prevent bleeding episodes in hemophilia patients
NCT ID NCT07545395
First seen May 02, 2026 · Last updated May 25, 2026 · Updated 5 times
Summary
This study is testing a medicine called KN057 as a long-term preventive treatment for people with hemophilia A or B, including those whose bodies have developed inhibitors that make standard treatments less effective. About 70 participants aged 12 to 65 will receive weekly injections of KN057 for up to 52 weeks to see if it is safe and helps prevent bleeding episodes. The study also compares two different manufacturing processes of the drug to ensure they work similarly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPHILIA A OR B are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences
RECRUITINGTianjin, Tianjin Municipality, 300020, China
Contact
Conditions
Explore the condition pages connected to this study.